195
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Burkholderia pseudomallei: In vitro susceptibility to some new and old antimicrobials

&
Pages 858-861 | Received 07 Mar 2007, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

D Mark Estes, Steven W Dow, Herbert P Schweizer & Alfredo G Torres. (2010) Present and future therapeutic strategies for melioidosis and glanders. Expert Review of Anti-infective Therapy 8:3, pages 325-338.
Read now

Articles from other publishers (15)

Sukripong Pakdeerat, Phumrapee Boonklang, Kesorn Angchagun, Chalita Chomkatekaew, Navaporn Apichaidejudom, Yaowaret Dokket, Areeya Faosap, Gumphol Wongsuwan, Vanaporn Wuthiekanun, Panatda Aramrueung, Phadungkiat Khamnoi, Hathairat Thananchai, Suwattiya Siriboon, Parinya Chamnan, Sharon J Peacock, Nicholas P J Day, Nicholas R Thomson, Chayasith Uttamapinant, Somsakul Pop Wongpalee & Claire Chewapreecha. (2024) Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in low-income and middle-income countries: a molecular diagnostics study. The Lancet Microbe 5:4, pages e379-e389.
Crossref
S Nisarg, Praveen Kumar Tirlangi, Prithvishree Ravindra, Rachana Bhat, Sachin Nayak Sujir, Sai Deepak Alli, Soumi Chowdhury, Venkat Abhiram Earny, Nitin Gupta & Chiranjay Mukhopadhyay. (2024) Predictors of 28-day mortality in melioidosis patients presenting to an emergency department: a retrospective cohort study from South India. Transactions of The Royal Society of Tropical Medicine and Hygiene.
Crossref
Ainulkhir Hussin, Mohd Yusof Nor Rahim, Frederick Dalusim, Muhammad Ashraf Shahidan, Sheila Nathan & Nazlina Ibrahim. (2023) Improving the clinical recognition, prognosis, and treatment of melioidosis through epidemiology and clinical findings: The Sabah perspective. PLOS Neglected Tropical Diseases 17:10, pages e0011696.
Crossref
Nicole Aiosa, Anupama Sinha, Olakunle A. Jaiyesimi, Ricardo R. da Silva, Steven S. Branda & Neha Garg. (2022) Metabolomics Analysis of Bacterial Pathogen Burkholderia thailandensis and Mammalian Host Cells in Co-culture . ACS Infectious Diseases 8:8, pages 1646-1662.
Crossref
Stephen H. Zinner & Kenneth H. Mayer. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 410 418.e2 .
S. Maloney, C. Engler & R. Norton. (2014) In vitro activity of ceftaroline against Burkholderia pseudomallei. Journal of Antimicrobial Chemotherapy 69:6, pages 1716-1718.
Crossref
Norazah Ahmad, Rohaidah Hashim & Azura Mohd Noor. (2013) The In Vitro Antibiotic Susceptibility of Malaysian Isolates of Burkholderia pseudomallei . International Journal of Microbiology 2013, pages 1-7.
Crossref
Rebecca Lipsitz, Susan Garges, Rosemarie Aurigemma, Prasith Baccam, David D. Blaney, Allen C. Cheng, Bart J. Currie, David Dance, Jay E. Gee, Joseph Larsen, Direk Limmathurotsakul, Meredith G. Morrow, Robert Norton, Elizabeth O’Mara, Sharon J. Peacock, Nicki Pesik, L. Paige Rogers, Herbert P. Schweizer, Ivo Steinmetz, Gladys Tan, Patrick Tan, W. Joost Wiersinga, Vanaporn Wuthiekanun & Theresa L. Smith. (2012) Workshop on Treatment of and Postexposure Prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010 . Emerging Infectious Diseases 18:12, pages e2-e2.
Crossref
Patrick Harris, Cathy Engler & Robert Norton. (2011) Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin. International Journal of Antimicrobial Agents 37:6, pages 547-549.
Crossref
Wipa Suginta, Kozhinjampara R. Mahendran, Watcharin Chumjan, Eric Hajjar, Albert Schulte, Mathias Winterhalter & Helge Weingart. (2011) Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain. Biochimica et Biophysica Acta (BBA) - Biomembranes 1808:6, pages 1552-1559.
Crossref
S Ramasamy, CQ Liu, H Tran, A Gubala, P Gauci, J McAllister & T Vo. (2010) Principles of antidote pharmacology: an update on prophylaxis, post‐exposure treatment recommendations and research initiatives for biological agents. British Journal of Pharmacology 161:4, pages 721-748.
Crossref
I-Ching Sam, Kah Heng See & Savithri D. Puthucheary. (2010) Susceptibility of Burkholderia pseudomallei to tigecycline and other antimicrobials. Diagnostic Microbiology and Infectious Disease 67:3, pages 308-309.
Crossref
STEPHEN H. ZINNER & KENNETH H. MAYER. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 475 486 .
Barbara M Judy, Gregory C Whitlock, Alfredo G Torres & D Mark Estes. (2009) Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin. BMC Microbiology 9:1.
Crossref
Visanu Thamlikitkul & Suwanna Trakulsomboon. (2009) In Vitro Activity of Doripenem against Burkholderia pseudomallei . Antimicrobial Agents and Chemotherapy 53:7, pages 3115-3117.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.